BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20575024)

  • 81. BCL11A Expression in Non-Small Cell Lung Cancers.
    Kątnik E; Gomułkiewicz A; Piotrowska A; Grzegrzółka J; Kmiecik A; Ratajczak-Wielgomas K; Urbaniak A; Glatzel-Plucińska N; Błasiak P; Dzięgiel P
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372998
    [TBL] [Abstract][Full Text] [Related]  

  • 82. SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.
    Andrades A; Peinado P; Alvarez-Perez JC; Sanjuan-Hidalgo J; García DJ; Arenas AM; Matia-González AM; Medina PP
    Mol Cancer; 2023 Feb; 22(1):39. PubMed ID: 36810086
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells.
    Sheng Y; Ji Z; Zhao H; Wang J; Cheng C; Xu W; Wang X; He Y; Liu K; Li L; Voeltzel T; Maguer-Satta V; Gao WQ; Zhu HH
    Cell Prolif; 2019 Jul; 52(4):e12611. PubMed ID: 31054182
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Identification of sequence variants influencing immunoglobulin levels.
    Jonsson S; Sveinbjornsson G; de Lapuente Portilla AL; Swaminathan B; Plomp R; Dekkers G; Ajore R; Ali M; Bentlage AEH; Elmér E; Eyjolfsson GI; Gudjonsson SA; Gullberg U; Gylfason A; Halldorsson BV; Hansson M; Holm H; Johansson Å; Johnsson E; Jonasdottir A; Ludviksson BR; Oddsson A; Olafsson I; Olafsson S; Sigurdardottir O; Sigurdsson A; Stefansdottir L; Masson G; Sulem P; Wuhrer M; Wihlborg AK; Thorleifsson G; Gudbjartsson DF; Thorsteinsdottir U; Vidarsson G; Jonsdottir I; Nilsson B; Stefansson K
    Nat Genet; 2017 Aug; 49(8):1182-1191. PubMed ID: 28628107
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.
    Del Giudice I; Marinelli M; Wang J; Bonina S; Messina M; Chiaretti S; Ilari C; Cafforio L; Raponi S; Mauro FR; Di Maio V; De Propris MS; Nanni M; Ciardullo C; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R
    Br J Haematol; 2016 Feb; 172(3):371-383. PubMed ID: 26597680
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.
    Xu-Monette ZY; Tu M; Jabbar KJ; Cao X; Tzankov A; Visco C; Nagarajan L; Cai Q; Montes-Moreno S; An Y; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Miranda RN; Medeiros LJ; Young KH
    Oncotarget; 2015 Mar; 6(8):5615-33. PubMed ID: 25760242
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation.
    Klauke K; Radulović V; Broekhuis M; Weersing E; Zwart E; Olthof S; Ritsema M; Bruggeman S; Wu X; Helin K; Bystrykh L; de Haan G
    Nat Cell Biol; 2013 Apr; 15(4):353-62. PubMed ID: 23502315
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The c-Rel Transcription Factor in Development and Disease.
    Gilmore TD; Gerondakis S
    Genes Cancer; 2011 Jul; 2(7):695-711. PubMed ID: 22207895
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.
    Migliazza A; Cayanis E; Bosch-Albareda F; Komatsu H; Martinotti S; Toniato E; Kalachikov S; Bonaldo MF; Jelene P; Ye X; Rzhetsky A; Qu X; Chien M; Inghirami G; Gaidano G; Vitolo U; Saglio G; Resegotti L; Zhang P; Soares MB; Russo J; Fischer SG; Edelman IS; Efstratiadis A; Dalla-Favera R
    Curr Top Microbiol Immunol; 2000; 252():275-84. PubMed ID: 11125485
    [No Abstract]   [Full Text] [Related]  

  • 90. The MYCN oncoprotein as a drug development target.
    Lu X; Pearson A; Lunec J
    Cancer Lett; 2003 Jul; 197(1-2):125-30. PubMed ID: 12880971
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia.
    Deambrogi C; De Paoli L; Fangazio M; Cresta S; Rasi S; Spina V; Gattei V; Gaidano G; Rossi D
    Am J Hematol; 2010 Jul; 85(7):541-4. PubMed ID: 20575024
    [No Abstract]   [Full Text] [Related]  

  • 92. Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.
    Ma D; Chen Z; Patel KP; Mishra BM; Yao H; Abruzzo LV; Medeiros LJ; Wierda W; Keating M; Sargent R; Luthra R
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S17-24. PubMed ID: 22035742
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
    Martín-Subero JI; Gesk S; Harder L; Sonoki T; Tucker PW; Schlegelberger B; Grote W; Novo FJ; Calasanz MJ; Hansmann ML; Dyer MJ; Siebert R
    Blood; 2002 Feb; 99(4):1474-7. PubMed ID: 11830502
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.
    Satterwhite E; Sonoki T; Willis TG; Harder L; Nowak R; Arriola EL; Liu H; Price HP; Gesk S; Steinemann D; Schlegelberger B; Oscier DG; Siebert R; Tucker PW; Dyer MJ
    Blood; 2001 Dec; 98(12):3413-20. PubMed ID: 11719382
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.
    Chapiro E; Leporrier N; Radford-Weiss I; Bastard C; Mossafa H; Leroux D; Tigaud I; De Braekeleer M; Terré C; Brizard F; Callet-Bauchu E; Struski S; Veronese L; Fert-Ferrer S; Taviaux S; Lesty C; Davi F; Merle-Béral H; Bernard OA; Sutton L; Raynaud SD; Nguyen-Khac F
    Leuk Res; 2010 Jan; 34(1):63-8. PubMed ID: 19406473
    [TBL] [Abstract][Full Text] [Related]  

  • 96. MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification.
    Valent A; Le Roux G; Barrois M; Terrier-Lacombe MJ; Valteau-Couanet D; Léon B; Spengler B; Lenoir G; Bénard J; Bernheim A
    J Pathol; 2002 Dec; 198(4):495-501. PubMed ID: 12434419
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.